12 / 12
Page 68
Notes:
conferenceseries
.com
Volume 8, Issue 5 (Suppl)
J Addict Res Ther, an open access journal
ISSN: 2155-6105
6
th
World Congress on
August 29-31, 2017 | Prague, Czech Republic
Addiction Disorder & Addiction Therapy
Addiction Congress 2017
August 29-31, 2017
The prevalence of B12 deficiency in patients with methamphetamine abuse
Mahsa Houshdar
Ghaem General Hospital of Karaj, Iran
M
ethamphetamine abuse can make neurological damages. These neurological damages may remain even after disruption
of abuse. In this study, we inspected the prevalence of B12 deficiency in the methamphetamine abuser patients as a factor
that can make longitudinal brain damages.
Method:
We visited all the patients that referred to “Afarinesh” addiction clinic in Iran, and asked them whether they have
had any vitamin B12 injections or eating along their metamphetamine abusing period. If the answer was negative, we would
measure their serum vitamin B12 level.
Result:
14 of the volunteers were suitable for this study. All of them were men and their age varied between 25 to 43 years.
The average age was 29 years. In 3 patients out of 14 patients, the serum vitamin B12 level was under 200pg/ml. This study
showed that 21 percent of the patients with metamphetamine abuse significantly suffered from VitaminB12 deficiency. In
5 other patients, the serum Vitamin B12 level was between 200 and 350pg/ml. This study showed that 35 percent of the
patients with metamphetamine abuse may suffer from covered Vitamin B12 deficiency and they need other tests such as serum
methylmalonic acid level for diagnosing Vitamin B12 deficiency.
Conclusion:
Regarding to the high prevalence of serum Vitamin B12 deficiency in the patients with metamphetamine abuse,
in this field, a case control study is recommended.
mhooshdar@gmail.comMahsa Houshdar, J Addict Res Ther 2017, 8:5 (Suppl)
DOI: 10.4172/2155-6105-C1-034